Literature DB >> 21365338

Bioactive glass 13-93 as a subchondral substrate for tissue-engineered osteochondral constructs: a pilot study.

Prakash Jayabalan1, Andrea R Tan, Mohammed N Rahaman, B Sonny Bal, Clark T Hung, James L Cook.   

Abstract

BACKGROUND: Replacement of diseased areas of the joint with tissue-engineered osteochondral grafts has shown potential in the treatment of osteoarthritis. Bioactive glasses are candidates for the osseous analog of these grafts. QUESTIONS/PURPOSES: (1) Does Bioactive Glass 13-93 (BG 13-93) as a subchondral substrate improve collagen and glycosaminoglycan production in a tissue-engineered cartilage layer? (2) Does BG 13-93 as a culture medium supplement increase the collagen and glycosaminoglycan production and improve the mechanical properties in a tissue-engineered cartilage layer?
METHODS: In Study 1, bioactive glass samples (n = 4) were attached to a chondrocyte-seeded agarose layer to form an osteochondral construct, cultured for 6 weeks, and compared to controls. In Study 2, bioactive glass samples (n = 5) were cocultured with cell-seeded agarose for 6 weeks. The cell-seeded agarose layer was exposed to BG 13-93 either continuously or for the first or last 2 weeks in culture or had no exposure.
RESULTS: Osteochondral constructs with a BG 13-93 base had improved glycosaminoglycan deposition but less collagen II content. Agarose scaffolds that had a temporal exposure to BG 13-93 within the culture medium had improved mechanical and biochemical properties compared to continuous or no exposure.
CONCLUSIONS: When used as a subchondral substrate, BG 13-93 did not improve biochemical properties compared to controls. However, as a culture medium supplement, BG 13-93 improved the biochemical and mechanical properties of a tissue-engineered cartilage layer. CLINICAL RELEVANCE: BG 13-93 may not be suitable in osteochondral constructs but could have potential as a medium supplement for neocartilage formation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21365338      PMCID: PMC3171527          DOI: 10.1007/s11999-011-1818-x

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  40 in total

1.  Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass 45S5 dissolution.

Authors:  I D Xynos; A J Edgar; L D Buttery; L L Hench; J M Polak
Journal:  J Biomed Mater Res       Date:  2001-05

2.  Interactions of bioactive glasses with osteoblasts in vitro: effects of 45S5 Bioglass, and 58S and 77S bioactive glasses on metabolism, intracellular ion concentrations and cell viability.

Authors:  I A Silver; J Deas; M Erecińska
Journal:  Biomaterials       Date:  2001-01       Impact factor: 12.479

3.  Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin-like growth factor II mRNA expression and protein synthesis.

Authors:  I D Xynos; A J Edgar; L D Buttery; L L Hench; J M Polak
Journal:  Biochem Biophys Res Commun       Date:  2000-09-24       Impact factor: 3.575

4.  In vivo outcomes of tissue-engineered osteochondral grafts.

Authors:  B Sonny Bal; Mohamed N Rahaman; Prakash Jayabalan; Keiichi Kuroki; Mary K Cockrell; Jian Q Yao; James L Cook
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2010-04       Impact factor: 3.368

5.  Type I collagen production by osteoblast-like cells cultured in contact with different bioactive glasses.

Authors:  Michela Bosetti; Laura Zanardi; Larry Hench; Mario Cannas
Journal:  J Biomed Mater Res A       Date:  2003-01-01       Impact factor: 4.396

6.  Mechanoregulation of chondrocyte proliferation, maturation, and hypertrophy: ion-channel dependent transduction of matrix deformation signals.

Authors:  Q Q Wu; Q Chen
Journal:  Exp Cell Res       Date:  2000-05-01       Impact factor: 3.905

7.  Evaluation of osteoblast response to porous bioactive glass (45S5) substrates by RT-PCR analysis.

Authors:  E A Effah Kaufmann; P Ducheyne; I M Shapiro
Journal:  Tissue Eng       Date:  2000-02

8.  Functional tissue engineering of chondral and osteochondral constructs.

Authors:  Eric G Lima; Robert L Mauck; Shelley H Han; Seonghun Park; Kenneth W Ng; Gerard A Ateshian; Clark T Hung
Journal:  Biorheology       Date:  2004       Impact factor: 1.875

Review 9.  Articular cartilage injuries.

Authors:  J A Buckwalter
Journal:  Clin Orthop Relat Res       Date:  2002-09       Impact factor: 4.176

10.  Fresh osteochondral allografts.

Authors:  William D Bugbee
Journal:  J Knee Surg       Date:  2002       Impact factor: 2.757

View more
  4 in total

Review 1.  Bioactive glass in tissue engineering.

Authors:  Mohamed N Rahaman; Delbert E Day; B Sonny Bal; Qiang Fu; Steven B Jung; Lynda F Bonewald; Antoni P Tomsia
Journal:  Acta Biomater       Date:  2011-03-21       Impact factor: 8.947

Review 2.  Osteochondral tissue engineering: scaffolds, stem cells and applications.

Authors:  Patcharakamon Nooeaid; Vehid Salih; Justus P Beier; Aldo R Boccaccini
Journal:  J Cell Mol Med       Date:  2012-10       Impact factor: 5.310

Review 3.  Crosstalk between Substrates and Rho-Associated Kinase Inhibitors in Cryopreservation of Tissue-Engineered Constructs.

Authors:  Arindam Bit; Awanish Kumar; Abhishek Kumar Singh; Albert A Rizvanov; Andrey P Kiassov; Pradeep Kumar Patra; Munish Kumar; Akalabya Bissoyi
Journal:  Stem Cells Int       Date:  2017-10-19       Impact factor: 5.443

4.  Cobalt-containing bioactive glasses reduce human mesenchymal stem cell chondrogenic differentiation despite HIF-1α stabilisation.

Authors:  E Littmann; H Autefage; A K Solanki; C Kallepitis; J R Jones; M Alini; M Peroglio; M M Stevens
Journal:  J Eur Ceram Soc       Date:  2018-03       Impact factor: 5.302

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.